Chembio Diagnostics Cash Conversion Cycle 2011-2026 | CEMI

Annual Cash Conversion Cycle Chembio Diagnostics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
111	120	144	144	153	114	143	97.9	146	85.8	88.5	94.5

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
153	85.8	120

Quarterly Cash Conversion Cycle Chembio Diagnostics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	46.9	-	85.9	-	156	246	228	-	113	170	185	-	123	118	156	-	36.5	138	130	31.8	90.8	168	39.5	72.6	82.4	94.5	40.1	50	32.1	32.9	78.8	-	104	103	101	-	43.6	77.7	64.3	-	87.9	72.3	53.6	-	46.2	75.7	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
246	31.8	96.6

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Biomerica BMRA	172	$ 2.13	-2.74 %	$ 4.89 M	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Castle Biosciences CSTL	45.9	$ 25.75	3.0 %	$ 715 M	USA
Quest Diagnostics Incorporated DGX	39.5	$ 195.6	0.17 %	$ 21.7 B	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	-38.7	-	-6.19 %	$ 10.5 M	USA
DexCom DXCM	134	$ 65.94	-1.51 %	$ 25.7 B	USA
Co-Diagnostics CODX	299	$ 4.4	101.83 %	$ 129 M	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	42.5	$ 104.91	-	$ 19.8 B	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	42.4	$ 16.33	5.29 %	$ 494 M	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Charles River Laboratories International CRL	65	$ 158.0	2.86 %	$ 7.83 B	USA
IQVIA Holdings IQV	73.9	$ 166.96	0.54 %	$ 28.7 B	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
BioNano Genomics BNGO	166	$ 1.46	26.96 %	$ 1.86 M	USA
Interpace Biosciences IDXG	44.9	$ 1.71	0.73 %	$ 7.5 M	USA
IDEXX Laboratories IDXX	103	$ 578.51	0.22 %	$ 46.5 B	USA
Agilent Technologies A	111	$ 112.02	0.65 %	$ 34.1 B	USA
Illumina ILMN	142	$ 123.79	-0.43 %	$ 19.7 B	USA
ICON Public Limited Company ICLR	62	$ 100.35	0.65 %	$ 8.28 B	Irlanda
DarioHealth Corp. DRIO	115	$ 7.5	-6.13 %	$ 29.9 M	Israel
Guardant Health GH	79.6	$ 84.9	-0.33 %	$ 10.6 B	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
CareDx, Inc CDNA	51.5	$ 17.56	2.39 %	$ 936 M	USA
Lantheus Holdings LNTH	97.3	$ 75.73	-0.92 %	$ 5.11 B	USA
Medpace Holdings MEDP	50.4	$ 456.93	0.98 %	$ 13.2 B	USA
Laboratory Corporation of America Holdings LH	40.3	$ 264.42	0.54 %	$ 22 B	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	66.4	$ 1 239.07	2.87 %	$ 25.5 B	Schweiz
Myriad Genetics MYGN	49.3	$ 4.66	1.75 %	$ 432 M	USA
ENDRA Life Sciences NDRA	-1.24 K	$ 3.48	0.87 %	$ 1.87 M	USA
NeoGenomics NEO	82.4	$ 8.1	1.76 %	$ 1.04 B	USA
National Research Corporation NRC	29.4	$ 17.51	1.1 %	$ 392 M	USA
Natera NTRA	81.5	$ 200.09	2.46 %	$ 19.7 B	USA
OPKO Health OPK	242	$ 1.15	2.68 %	$ 798 M	USA
Pacific Biosciences of California PACB	185	$ 1.39	4.51 %	$ 417 M	USA
RadNet RDNT	34.5	$ 61.74	0.41 %	$ 4.64 B	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA